1. Home
  2. MDGL vs FR Comparison

MDGL vs FR Comparison

Compare MDGL & FR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • FR
  • Stock Information
  • Founded
  • MDGL 2011
  • FR 1993
  • Country
  • MDGL United States
  • FR United States
  • Employees
  • MDGL N/A
  • FR N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • FR Real Estate Investment Trusts
  • Sector
  • MDGL Health Care
  • FR Real Estate
  • Exchange
  • MDGL Nasdaq
  • FR Nasdaq
  • Market Cap
  • MDGL 6.1B
  • FR 6.9B
  • IPO Year
  • MDGL N/A
  • FR 1994
  • Fundamental
  • Price
  • MDGL $417.43
  • FR $51.74
  • Analyst Decision
  • MDGL Strong Buy
  • FR Buy
  • Analyst Count
  • MDGL 10
  • FR 10
  • Target Price
  • MDGL $474.67
  • FR $54.80
  • AVG Volume (30 Days)
  • MDGL 329.8K
  • FR 881.6K
  • Earning Date
  • MDGL 10-30-2025
  • FR 10-15-2025
  • Dividend Yield
  • MDGL N/A
  • FR 3.44%
  • EPS Growth
  • MDGL N/A
  • FR N/A
  • EPS
  • MDGL N/A
  • FR 2.05
  • Revenue
  • MDGL $515,547,000.00
  • FR $700,534,000.00
  • Revenue This Year
  • MDGL $394.12
  • FR $10.83
  • Revenue Next Year
  • MDGL $57.74
  • FR $7.12
  • P/E Ratio
  • MDGL N/A
  • FR $25.29
  • Revenue Growth
  • MDGL 3421.98
  • FR 8.80
  • 52 Week Low
  • MDGL $200.63
  • FR $40.31
  • 52 Week High
  • MDGL $457.16
  • FR $58.17
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 54.19
  • FR 54.10
  • Support Level
  • MDGL $418.36
  • FR $51.60
  • Resistance Level
  • MDGL $440.90
  • FR $52.88
  • Average True Range (ATR)
  • MDGL 13.63
  • FR 0.94
  • MACD
  • MDGL -5.66
  • FR -0.07
  • Stochastic Oscillator
  • MDGL 4.56
  • FR 34.20

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About FR First Industrial Realty Trust Inc.

First Industrial Realty Trust Inc is a real estate investment trust that owns, manages, acquires, sells, develops, and redevelops industrial real estate. Through its fully integrated operating and investing platform, the company provides facilities and customer service to multinational corporations and regional firms that are essential for their supply chains. The company serves a diverse tenant base across various sectors, including e-commerce, logistics, transportation, manufacturing, retail, consumer services, food and beverage, building materials, wholesale goods, health services, and government.

Share on Social Networks: